glutathione mutations in sclc patients Increased antioxidative defense and reduced advanced glycation end-product formation by metabolic adaptation non-small-cell-lung-cancer Cell Death, Molecular Targeted Therapies,
Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR Mutant Lung Cancer The flavonoid GL V9 induces oxidative stress mediated apoptosis in small cell lung cancer by promoting STEAP3 degradation ScienceDirect Inhibiting the system xC glutathione axis selectively targets cancers with mutant p53 accumulation Nature Communications In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances
Pay in 4 interest-free payments of $7.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



